Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04888169 · ClinicalTrials.gov registry record · NA
Studying the Modification of Attention Bias Remotely After Trauma
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,314
- Enrollment target
NCT04888169 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,314 participants.
The verdict
NCT04888169, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,314 participants
- Enrollment target
Study Summary
The investigators will complete an entirely remote randomized controlled trial (RCT) comparing 14 sessions of attention bias modification (ABM), attention control training (ACT), placebo neutral attention training, and a final control condition with daily questions in 1,897 individuals with clinically significant Post-traumatic Stress Symptoms (PTSS) (defined as PCL-5 score ≥ 33). To assess effects of the training and control conditions, the investigators will administer tests of threat-related attention bias and variability, and self-report assessments of PTSS, depression, anxiety, and perceived stress at baseline, after one and two weeks of training, and at eight-week follow up. The investigators plan to screen and confirm interest from over 3,000 eligible participants over a period of 24 months to enroll and randomize 1,897 participants with the end goal of 1,232 completers (176 per condition).
Interventions
- DEVICE SMART Mobile App - Attention Bias Modification
- DEVICE SMART Mobile App - Attention Control Training
- DEVICE SMART Mobile App - Placebo Training
- DEVICE SMART Mobile App - Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,314 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04888169
The ClinicalTrials.gov registry entry for NCT04888169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which SMART Mobile App - Attention Bias Modification is the first listed.
NCT04888169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04888169 about?
NCT04888169 is a clinical study titled "Studying the Modification of Attention Bias Remotely After Trauma". The investigators will complete an entirely remote randomized controlled trial (RCT) comparing 14 sessions of attention bias modification (ABM), attention control training (ACT), placebo neutral attention training, and a final control condition with daily questions in 1,897 individuals with clinical...
What is the current status of trial NCT04888169?
This trial is currently completed. It is a NA study. The enrollment target is 1,314 participants. The study started on 2023-04-20. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT04888169?
The interventions under investigation include: SMART Mobile App - Attention Bias Modification (DEVICE), SMART Mobile App - Attention Control Training (DEVICE), SMART Mobile App - Placebo Training (DEVICE), SMART Mobile App - Control (DEVICE).
Who is sponsoring clinical trial NCT04888169?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.